학술논문

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Document Type
Article
Source
In International Journal of Radiation Oncology, Biology, Physics 15 July 2020 107(4):720-725
Subject
Central Nervous System Tumor
Language
ISSN
0360-3016